Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kenvue Inc. Common Stock
(NY:
KVUE
)
24.44
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kenvue Inc. Common Stock
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
3 Things About Johnson & Johnson That Smart Investors Know
September 27, 2023
J&J shares have missed out on the market rally so far this year.
Via
The Motley Fool
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation - KVUE
September 26, 2023
WHY: NEW YORK, NY - (NewMediaWire) - September 25, 2023 - Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of...
Via
TheNewswire.com
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation - KVUE
September 25, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
3 Best Stocks to Buy in September and Hold Forever
September 24, 2023
Healthcare blue chip stocks with proven track records can be excellent long-term investments.
Via
The Motley Fool
3 Reasons SharkNinja Is Swimming Toward New Highs
September 22, 2023
Shares of SharkNinja, Inc. are up more than 50% since August 4th — and becoming a popular momentum bet amongst retail traders.
Via
MarketBeat
Check Out What Whales Are Doing With KVUE
September 19, 2023
Via
Benzinga
Looking Into Kenvue's Recent Short Interest
September 18, 2023
Via
Benzinga
Kenvue Unusual Options Activity For September 13
September 13, 2023
Via
Benzinga
Kenvue to Announce Third Quarter 2023 Results on October 26, 2023
September 22, 2023
From
Kenvue Inc.
Via
Business Wire
KVUE INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Inquire About Securities Class Action Investigation – KVUE
September 21, 2023
From
Rosen Law Firm
Via
Business Wire
2 Incredibly Cheap Dividend Stocks to Buy Now
September 20, 2023
High-quality dividend stocks are rarely cheap. These two names are an exception.
Via
The Motley Fool
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
September 19, 2023
Discover how these seven standout companies offer both security and growth potential in an uncertain financial landscape.
Via
InvestorPlace
3 High-Quality Dividend Stocks Yielding 3%-Plus to Buy for Decades of Rising Income
September 17, 2023
These companies generate durable and growing cash flows.
Via
The Motley Fool
Better Buy: J&J vs. Kenvue
September 13, 2023
You can count on both of these companies for passive income, too.
Via
The Motley Fool
Analyst Ratings for Kenvue
September 11, 2023
Via
Benzinga
Kenvue Unusual Options Activity
September 07, 2023
Via
Benzinga
Why Jim Cramer Warns Investors To Avoid This Stock Up Over 90% This Year
September 15, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said UiPath Inc. (NYSE: PATH) is a "decent" stock. Cramer said the company is not making money, and he doesn’t recommend stocks that don’t make money.
Via
Benzinga
3 Great Dividend Stocks You Can Buy for Less Than $50
September 15, 2023
These steady-Eddie operators are perfect bedrock stocks for investors despite trading for less than $50.
Via
The Motley Fool
3 Blue-Chip Stocks to Watch in the ‘Green Zone’
September 14, 2023
Now may be the time to take a look at these three blue-chips, as each one is currently in the "Green Zone stocks" category.
Via
InvestorPlace
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...
Via
Benzinga
Exposures
Product Safety
Is J&J a Buy After the Kenvue Separation?
September 06, 2023
J&J shares have been on the decline.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 11, 2023
September 11, 2023
Via
Benzinga
Bargain Hunting With $100? This New S&P 500 Dividend Stock Is a No-Brainer to Buy on the Dip
September 10, 2023
The market may be sleeping on this dividend stock, down 19% in its short history as a stand-alone business.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
The 7 Best Dow Stocks to Buy Now: September 2023
September 08, 2023
These are the best Dow stocks to buy because they offer long-term growth, a margin of safety and reliability in an otherwise volatile market.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
J&J Spinoff Kenvue is the New Dividend Aristocrat on the Block
September 07, 2023
Newly public company Kenvue, a spinoff from Johnson & Johnson, joins the ranks of dividend aristocrats, offering a 3.57% yield, and 2022 sales of $15 billion.
Via
MarketBeat
Topics
ETFs
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
September 07, 2023
Via
Benzinga
1 Brand-New Dividend Stock Income Investors Won't Want to Miss
September 07, 2023
The recently spun-off Kenvue looks to be a high-quality dividend stock.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
Via
Benzinga
Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories
September 05, 2023
Benzinga Why Facebook News is Shutting Down in Europe: What It Means for Users?
Via
Benzinga
Johnson & Johnson's Growth Strategy Post Tylenol Parent Kenvue Split: Paving the Way for Medical Innovation
September 05, 2023
Johnson & Johnson (NYSE: JNJ) is gearing up to use the proceeds from the recent separation of its consumer-health segment Kenvue Inc (NYSE: KVUE) to bolster its growth in
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.